Updates

CSRXP RELEASES MEMBER PACKET FOR 117TH CONGRESS

Feb 8, 2021

Resource Provides Information on Out-of-Control Drug Prices — Outlines Read More

ICYMI: NEW REPORT DEBUNKS BOGUS BIG PHARMA RHETORIC THAT SOLUTIONS TO LOWER DRUG PRICES WILL CRIMP INNOVATION

Feb 4, 2021

Study Finds Solutions to Make Medications More Accessible Will Not Restrict Read More

BIG PHARMA EARNINGS WATCH: GLAXOSMITHKLINE & ABBVIE

Feb 4, 2021

Brand Name Pharma Giants Surpass Expectations While Hiking Prices During Read More

BIG PHARMA EARNINGS WATCH: PFIZER & AMGEN

Feb 3, 2021

Big Pharma Giants See Profits Jump After New Year Price Hikes New earnings Read More

BIG PHARMA EARNINGS WATCH: ELI LILLY

Jan 29, 2021

Brand Name Drug Company Sees Soaring Profits After Hiking Prices Today Read More

CSRxP: BIDEN ADMINISTRATION TAKES IMPORTANT STEP TO PROTECT SENIORS & TAXPAYERS WITH DELAY OF REBATE RULE

Jan 29, 2021

HHS Pause of Misguided, Pharma-Backed Policy Will Help Refocus Attention on Read More

ICYMI: STUDY FINDS U.S. BRAND NAME DRUG PRICES “SIGNIFICANTLY HIGHER” THAN THOSE IN OTHER COUNTRIES

Jan 28, 2021

New RAND Report Finds Rx Prices in U.S. Average 3.44 Times Higher Than Those Read More

PRESCRIPTION FOR CHANGE: WHY DRUG PRICES ARE OUT-OF-CONTROL AND HOW TO FIX IT

Jan 28, 2021

CSRxP Briefing Covers Impact of Affordability Crisis, Drug Company’s Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON & NOVARTIS

Jan 27, 2021

Price Hikes Fuel Sky-High Earnings For Brand Name Giants As millions of Read More

CSRXP POLL: AMERICANS EXPECT NEW ADMINISTRATION & CONGRESS TO ACT ON OUT-OF-CONTROL DRUG PRICES, HOLD BIG PHARMA ACCOUNTABLE

Jan 26, 2021

Clear Majority of Voters Identify Rx Drug Affordability as Top Issue and Read More

CSRXP WELCOMES GOVERNOR CUOMO INVESTIGATION OF DRUG COMPANIES’ PANDEMIC PRICE-GOUGING

Jan 22, 2021

Investigation Will Shed Light On Big Pharma’s Price Hikes During Public Read More

CSRXP: SENATE FINANCE REPORT HIGHLIGHTS BIG PHARMA’S EGREGIOUS PRACTICES THAT RAISE INSULIN PRICES

Jan 14, 2021

Bipartisan Investigation Details How Drug Companies Work in Tandem to Hike Read More